newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Submits Application for U.A.E. Marketing Authorization for Endari®

TORRANCE, Calif., Oct. 26, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced the submission of its application for m